Oliver Lagore Vanvalin Investment Group Glaukos Corp Transaction History
Oliver Lagore Vanvalin Investment Group
- $263 Million
- Q2 2025
A detailed history of Oliver Lagore Vanvalin Investment Group transactions in Glaukos Corp stock. As of the latest transaction made, Oliver Lagore Vanvalin Investment Group holds 75 shares of GKOS stock, worth $7,854. This represents 0.0% of its overall portfolio holdings.
Number of Shares
75Holding current value
$7,854% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding GKOS
# of Institutions
360Shares Held
50.2MCall Options Held
260KPut Options Held
776K-
Black Rock Inc. New York, NY8.04MShares$842 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.97MShares$625 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.29MShares$240 Million0.04% of portfolio
-
State Street Corp Boston, MA1.98MShares$208 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.94MShares$204 Million0.05% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $4.98B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...